Targeted Drug Delivery Systems: Strategies and Challenges
暂无分享,去创建一个
[1] Wolfgang Sadee,et al. 5′-Amino Acid Esters of Antiviral Nucleosides, Acyclovir, and AZT Are Absorbed by the Intestinal PEPT1 Peptide Transporter , 1998, Pharmaceutical Research.
[2] Vladimir P Torchilin,et al. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. , 2013, Biomaterials.
[3] Xin Liu,et al. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[4] Wei Huang,et al. Redox-responsive polyphosphate nanosized assemblies: a smart drug delivery platform for cancer therapy. , 2011, Biomacromolecules.
[5] S. Kawakami,et al. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[6] V. Torchilin,et al. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[7] O. Katare,et al. The pilosebaceous unit: a pivotal route for topical drug delivery. , 2000, Methods and findings in experimental and clinical pharmacology.
[8] D. Begley,et al. Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats , 2006, Journal of drug targeting.
[9] H. Szeto. Development of Mitochondria‐targeted Aromatic‐cationic Peptides for Neurodegenerative Diseases , 2008, Annals of the New York Academy of Sciences.
[10] Indu Pal Kaur,et al. Ocular Preparations: The Formulation Approach , 2002, Drug development and industrial pharmacy.
[11] Chih-Kuang Yeh,et al. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. , 2012, Biomaterials.
[12] Jeffrey I. Zink,et al. Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles , 2012, Antimicrobial Agents and Chemotherapy.
[13] T. Seki,et al. Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[14] V. Torchilin,et al. Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria. , 2012, Biomaterials.
[15] S. Santoyo,et al. PLGA microparticles: possible vehicles for topical drug delivery. , 2001, International journal of pharmaceutics.
[16] Chih-Kuang Yeh,et al. Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis. , 2012, Biomaterials.
[17] Sanyog Jain,et al. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. , 2005, International journal of pharmaceutics.
[18] P S Kim,et al. Mechanisms of viral membrane fusion and its inhibition. , 2001, Annual review of biochemistry.
[19] R. Pandey,et al. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. , 2005, Tuberculosis.
[20] Ashish Ranjan,et al. Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[21] F. Kratz,et al. Drug delivery in oncology : from basic research to cancer therapy , 2011 .
[22] K. Longmuir,et al. Liposomal Polyethyleneglycol and Polyethyleneglycol-Peptide Combinations for Active Targeting to Liver In Vivo , 2008 .
[23] Jean Gruenberg,et al. The endocytic pathway: a mosaic of domains , 2001, Nature Reviews Molecular Cell Biology.
[24] A. Petrillo,et al. Blood‐Brain Barrier Disruption for the Treatment of Malignant Brain Tumors: The National Program , 1998, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.
[25] M. Samanta,et al. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease , 2008, Brain Research.
[26] Eun Seong Lee,et al. Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types. , 2012, Biomaterials.
[27] Vladimir P. Torchilin,et al. Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting , 2013, Journal of drug delivery.
[28] Y. Cai,et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[29] Jayanth Panyam,et al. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. , 2010, Biomaterials.
[30] C. M. Gupta,et al. Tuftsin-bearing liposomes in treatment of macrophage-based infections. , 2000, Advanced drug delivery reviews.
[31] R. Ramanujan,et al. Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy. , 2010, Acta biomaterialia.
[32] R. Schiffelers,et al. Drug targeting systems for inflammatory disease: one for all, all for one. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[33] D. Ingber,et al. Shear-Activated Nanotherapeutics for Drug Targeting to Obstructed Blood Vessels , 2012, Science.
[34] D. Maurice,et al. Review: practical issues in intravitreal drug delivery. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[35] R. Hopkin,et al. Enzyme therapy for lysosomal storage disease: principles, practice, and prospects. , 2003, Annual review of genomics and human genetics.
[36] Chun-Ming Huang,et al. Development of nanoparticles for antimicrobial drug delivery. , 2010, Current medicinal chemistry.
[37] M. Dehouck,et al. Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes , 1987, The Journal of cell biology.
[38] S. Martel,et al. Co-encapsulation of magnetic nanoparticles and doxorubicin into biodegradable microcarriers for deep tissue targeting by vascular MRI navigation. , 2011, Biomaterials.
[39] Dieter Haemmerich,et al. Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: Computational modelling and preliminary in vivovalidation , 2012, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[40] D. A. Kharkevich,et al. Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles , 1997, Pharmaceutical Research.
[41] X. Wu,et al. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain. , 2010, Advanced drug delivery reviews.
[42] R. Niu,et al. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging. , 2012, International journal of pharmaceutics.
[43] D. Greiner,et al. Targeted Delivery of Small Interfering RNA to Human Dendritic Cells To Suppress Dengue Virus Infection and Associated Proinflammatory Cytokine Production , 2009, Journal of Virology.
[44] Z. Ram,et al. Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial , 2006, Acta Neurochirurgica.
[45] A S Kennedy,et al. A new catheter for tumor-targeting with radioactive microspheres in representative hepatic artery systems--part II: solid tumor-targeting in a patient-inspired hepatic artery system. , 2012, Journal of biomechanical engineering.
[46] Bhupinder Singh,et al. Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units. , 2009, Journal of liposome research.
[47] H. Takeuchi,et al. Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[48] Udita Agrawal,et al. Hyperbranched dendritic nano-carriers for topical delivery of dithranol , 2013, Journal of drug targeting.
[49] Y. Ogura,et al. Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis. , 2001, Investigative ophthalmology & visual science.
[50] Kenneth A Howard,et al. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[51] A. Hickey,et al. Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig. , 2006, The Journal of antimicrobial chemotherapy.
[52] E. Branch,et al. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. , 1998, JAMA.
[53] T. Cloughesy,et al. Pharmacological blood-brain barrier modification for selective drug delivery , 1995, Journal of Neuro-Oncology.
[54] G. Merlo,et al. Polyethylenimine-based intravenous delivery of transgenes to mouse lung , 1998, Gene Therapy.
[55] Y. Anraku,et al. Smart multilayered assembly for biocompatible siRNA delivery featuring dissolvable silica, endosome-disrupting polycation, and detachable PEG. , 2012, ACS nano.
[56] Sridhar Duvvuri,et al. Drug delivery to the retina: challenges and opportunities , 2003, Expert opinion on biological therapy.
[57] Roel Deckers,et al. Ultrasound triggered, image guided, local drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[58] Javed Ali,et al. Strategy for effective brain drug delivery. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[59] A. Klibanov,et al. Ultrasound triggered image-guided drug delivery. , 2009, European journal of radiology.
[60] W. Pardridge. Recent developments in peptide drug delivery to the brain. , 1992, Pharmacology & toxicology.
[61] M. Tanner,et al. Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02D malaria vaccine in infants living in a malaria-endemic region , 2013, Malaria Journal.
[62] A. Vorbrodt. Ultracytochemical characterization of anionic sites in the wall of brain capillaries , 1989, Journal of neurocytology.
[63] D. Begley,et al. Polysorbate‐80 coating enhances uptake of polybutylcyanoacrylate (PBCA)‐nanoparticles by human and bovine primary brain capillary endothelial cells , 2000, The European journal of neuroscience.
[64] Vladimir P Torchilin,et al. Nanopreparations to overcome multidrug resistance in cancer. , 2013, Advanced drug delivery reviews.
[65] W. Pardridge,et al. Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood–Brain Barrier in Vivo in the Primate , 1995, Pharmaceutical Research.
[66] M. Marmor. Structure and function of the retinal pigment epithelium. , 1975, International ophthalmology clinics.
[67] D. Begley. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. , 2004, Pharmacology & therapeutics.
[68] A. McHale,et al. Exploiting ultrasound-mediated effects in delivering targeted, site-specific cancer therapy. , 2010, Cancer letters.
[69] K. Takada,et al. Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs. , 1996, Journal of drug targeting.
[70] A. Ullrich,et al. Paul Ehrlich's magic bullet concept: 100 years of progress , 2008, Nature Reviews Cancer.
[71] J. Okwo-Bele,et al. Assessment of the RTS,S/AS01 malaria vaccine. , 2013, The Lancet. Infectious diseases.
[72] A. R. Kulkarni,et al. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[73] Lin Zhu,et al. Stimulus-responsive nanopreparations for tumor targeting. , 2013, Integrative biology : quantitative biosciences from nano to macro.
[74] Jürgen Lademann,et al. Follicular transport route--research progress and future perspectives. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[75] A. Dunaevsky. The gene-gun approach for transfection and labeling of cells in brain slices. , 2013, Methods in molecular biology.
[76] Wanyi Tai,et al. Prodrugs for improving tumor targetability and efficiency. , 2011, Advanced drug delivery reviews.
[77] Kumar Sharma,et al. Ultrasound Molecular Imaging of Tumor Angiogenesis With an Integrin Targeted Microbubble Contrast Agent , 2011, Investigative radiology.
[78] Vladimir Torchilin,et al. Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.
[79] Libo Yang,et al. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. , 2002, International journal of pharmaceutics.
[80] F. Knorr,et al. Hair Follicles – An Efficient Storage and Penetration Pathway for Topically Applied Substances , 2008, Skin Pharmacology and Physiology.
[81] W. Pardridge,et al. Biopharmaceutical drug targeting to the brain , 2010, Journal of drug targeting.
[82] V. Torchilin,et al. Targeting of lysosomes by liposomes modified with octadecyl-rhodamine B , 2011, Journal of drug targeting.
[83] A. Gupta,et al. Role of glutathione in cancer pathophysiology and therapeutic interventions. , 2012, Journal of experimental therapeutics & oncology.
[84] H. Yoshino,et al. In vivo drug release behavior in dogs from a new colon-targeted delivery system. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[85] Sanjay K. Jain,et al. Transferrin‐conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain , 2007, The Journal of pharmacy and pharmacology.
[86] Yi Jin,et al. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method. , 2008, International journal of pharmaceutics.
[87] R. Weissleder,et al. A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity , 2006, Molecular Cancer Therapeutics.
[88] Robert Gurny,et al. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. , 2003, Investigative ophthalmology & visual science.
[89] L. Rajendran,et al. Subcellular targeting strategies for drug design and delivery , 2010, Nature Reviews Drug Discovery.
[90] Vladimir P Torchilin,et al. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[91] M. Schäfer-Korting,et al. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. , 2000, International journal of pharmaceutics.
[92] Sanyog Jain,et al. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. , 2004, International journal of pharmaceutics.
[93] Stephen Neidle,et al. Cancer drug design and discovery , 2008 .
[94] I. Riemann,et al. Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles. , 2010, Biomaterials.
[95] K. Shakesheff,et al. Synthesis and Characterisation of a Degradable Poly(lactic acid)−Poly(ethylene glycol) Copolymer with Biotinylated End Groups , 2001 .
[96] Anthony N Price,et al. Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system. , 2010, Biomaterials.
[97] Vladimir P Torchilin,et al. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[98] Robert N Weinreb,et al. Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice. , 2002, Investigative ophthalmology & visual science.
[99] G. C. Cotzias,et al. Protein intake and treatment of Parkinson's disease with levodopa. , 1975, The New England journal of medicine.
[100] B. Sarmento,et al. Nanotechnology-based systems for the treatment and prevention of HIV/AIDS. , 2010, Advanced drug delivery reviews.
[101] P. Legrand,et al. Efficacy and Pharmacokinetics of Intravenous Nanocapsule Formulations of Halofantrine in Plasmodium berghei-Infected Mice , 2004, Antimicrobial Agents and Chemotherapy.
[102] N. K. Jain,et al. Lymphatic targeting of zidovudine using surface-engineered liposomes , 2008 .
[103] K. Longmuir,et al. Liposomes incorporating a Plasmodium amino acid sequence target heparan sulfate binding sites in liver. , 2008, Journal of pharmaceutical sciences.
[104] Arto Urtti,et al. Challenges and obstacles of ocular pharmacokinetics and drug delivery. , 2006, Advanced drug delivery reviews.
[105] Guangyan Zhou,et al. Discovery of small molecule fusion inhibitors targeting HIV-1 gp41. , 2013, Current pharmaceutical design.
[106] N. Mangini,et al. P-glycoprotein expression in human retinal pigment epithelium. , 2002, Molecular vision.
[107] N. K. Jain,et al. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting. , 2010, Advanced drug delivery reviews.
[108] Feng-Hou Gao,et al. Enhancing chemotherapeutic drug inhibition on tumor growth by ultrasound: an in vivo experiment , 2011, Journal of drug targeting.
[109] M. Tachikawa,et al. Inner Blood-Retinal Barrier Transporters: Role of Retinal Drug Delivery , 2009, Pharmaceutical Research.
[110] V. Torchilin,et al. “Smart” Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes , 2007, Journal of liposome research.
[111] Robert Langer,et al. Drugs on Target , 2001, Science.
[112] C. Chuang,et al. Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy. , 2011, Biomaterials.
[113] A. Basit,et al. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[114] Tommy Olsson,et al. The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy. , 2010, Biomaterials.
[115] A. Mitra,et al. Novel approaches to retinal drug delivery , 2007, Expert opinion on drug delivery.
[116] John Eisenbrey,et al. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. , 2011, International journal of pharmaceutics.
[117] G. S. Chhatwal,et al. Nano-technology for targeted drug delivery to combat antibiotic resistance , 2012, Expert opinion on drug delivery.
[118] A. Tsuji. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems , 2011, NeuroRX.
[119] A. Rawat,et al. Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles , 2006, Journal of drug targeting.
[120] V. Torchilin,et al. Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting , 2011, Journal of drug targeting.
[121] V. Torchilin,et al. Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery. , 2012, Biomaterials.
[122] Wei-Chiang Shen,et al. Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives , 2007, Pharmaceutical Research.
[123] H. Szeto. Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents , 2006, The AAPS Journal.
[124] H. Rakowski,et al. The use of cationic microbubbles to improve ultrasound-targeted gene delivery to the ischemic myocardium. , 2013, Biomaterials.
[125] Vladimir P. Torchilin,et al. Nanoparticulates as Drug Carriers , 2006 .
[126] Bernd Hauck,et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. , 2013, The New England journal of medicine.
[127] U. Blume-Peytavi,et al. Human hair follicle: reservoir function and selective targeting , 2011, The British journal of dermatology.
[128] F. J. Romero,et al. Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients , 1992, Documenta Ophthalmologica.
[129] Kevin Marsh,et al. Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. , 2013, The New England journal of medicine.
[130] Shailendra Joshi,et al. Enhanced Disruption of the Blood Brain Barrier by Intracarotid Mannitol Injection During Transient Cerebral Hypoperfusion in Rabbits , 2007, Journal of neurosurgical anesthesiology.
[131] M. Samanta,et al. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[132] K. Kotkow,et al. Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened , 2011, Clinical Cancer Research.
[133] A. Vulto,et al. Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats. , 2001, The Journal of antimicrobial chemotherapy.
[134] Chandana Mohanty,et al. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. , 2010, Biomaterials.
[135] Vladimir P Torchilin,et al. Effective stabilization and delivery of siRNA: reversible siRNA-phospholipid conjugate in nanosized mixed polymeric micelles. , 2010, Bioconjugate chemistry.
[136] K. Cal,et al. Targeting to the hair follicles: current status and potential. , 2010, Journal of dermatological science.
[137] Kamlesh Bhatt,et al. Host Innate Immune Response to Mycobacterium tuberculosis , 2007, Journal of Clinical Immunology.
[138] J. Lademann,et al. Follicular Penetration of Topically Applied Caffeine via a Shampoo Formulation , 2007, Skin Pharmacology and Physiology.
[139] C. Chuang,et al. Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer. , 2010, Biomaterials.
[140] M. C. Bonner,et al. Transfollicular drug delivery--is it a reality? , 2005, International journal of pharmaceutics.
[141] Takushi Kaneko,et al. Challenges and opportunities in developing novel drugs for TB. , 2011, Future medicinal chemistry.
[142] C. Springer,et al. Antibody-directed enzyme prodrug therapy (ADEPT) , 2007, Cell Biophysics.
[143] W. Pardridge. Blood-brain barrier drug targeting: the future of brain drug development. , 2003, Molecular interventions.
[144] V. Torchilin,et al. Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[145] V. Mosqueira,et al. Nanotechnology applied to the treatment of malaria. , 2010, Advanced drug delivery reviews.
[146] Feng-Yi Yang,et al. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[147] I. Chopra,et al. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections , 2010, Nature Reviews Microbiology.
[148] D. Friend,et al. Drug glycosides: potential prodrugs for colon-specific drug delivery. , 1985, Journal of medicinal chemistry.
[149] Robert J Levy,et al. Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[150] S Gordon,et al. Macrophage receptors and immune recognition. , 2005, Annual review of immunology.
[151] H. Maeda,et al. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[152] Jean-Pierre Benoit,et al. Active targeting of brain tumors using nanocarriers. , 2007, Biomaterials.
[153] Vladimir P Torchilin,et al. Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes. , 2011, International journal of pharmaceutics.
[154] V. Torchilin,et al. Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma. , 2014, Molecular pharmaceutics.
[155] S. Ménard,et al. Protection against doxorubicin‐induced alopecia in rats by liposome‐entrapped monoclonal antibodies , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[156] V. Torchilin. Targeted pharmaceutical nanocarriers for cancer therapy and imaging , 2007, The AAPS Journal.
[157] S. Achilefu,et al. A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy. , 2012, Biomaterials.
[158] Zhigang Wang,et al. Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[159] M. Robinson,et al. Recent advances in drug delivery systems for treating ocular complications of systemic diseases , 2009, Current opinion in ophthalmology.
[160] R. Umamaheshwari,et al. Receptor Mediated Targeting of Lectin Conjugated Gliadin Nanoparticles in the Treatment of Helicobacter pylori , 2003, Journal of drug targeting.
[161] K. P. Rao,et al. Azo polymeric hydrogels for colon targeted drug delivery. , 1995, Biomaterials.
[162] W. Cosolo,et al. Blood-brain barrier disruption using mannitol: time course and electron microscopy studies. , 1989, The American journal of physiology.
[163] V. Torchilin,et al. Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol , 2010, Journal of liposome research.
[164] K. Longmuir,et al. Binding patterns of peptide-containing liposomes in liver and spleen of developing mice: comparison with heparan sulfate immunoreactivity , 2011, Journal of drug targeting.
[165] Y. Ueda,et al. Comparative studies on the efficacy of AmBisome and Fungizone in a mouse model of disseminated aspergillosis , 2004 .
[166] Shuming Nie,et al. Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. , 2007, Journal of the American Chemical Society.
[167] T. Stylianopoulos. EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors. , 2013, Therapeutic delivery.
[168] N. McDannold,et al. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[169] R. Cecchelli,et al. Low‐Density Lipoprotein Receptor on Endothelium of Brain Capillaries , 1989, Journal of neurochemistry.
[170] S. Vyas,et al. Liposome-based drug delivery to alveolar macrophages , 2007, Expert opinion on drug delivery.
[171] J. Shea,et al. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[172] Y. Kawashima,et al. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. , 2001, The Journal of pharmacology and experimental therapeutics.
[173] You Han Bae,et al. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[174] Wolfgang Becker,et al. Nanoparticles and microparticles for skin drug delivery. , 2011, Advanced drug delivery reviews.
[175] Vladimir P Torchilin,et al. Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo. , 2009, International journal of pharmaceutics.
[176] Eric Arnoult,et al. The challenge of new drug discovery for tuberculosis , 2011, Nature.
[177] D. Do,et al. Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy , 2013, International journal of nanomedicine.
[178] V. Adam,et al. Magnetic nanoparticles and targeted drug delivering. , 2010, Pharmacological research.
[179] Qiang Zhang,et al. Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. , 2001, International journal of pharmaceutics.
[180] M. Polemis,et al. Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria , 2013, Scandinavian journal of infectious diseases.
[181] V. Torchilin,et al. Lysosome-targeted octadecyl-rhodamine B-liposomes enhance lysosomal accumulation of glucocerebrosidase in Gaucher's cells in vitro. , 2013, Nanomedicine.
[182] V. Torchilin,et al. Design and synthesis of novel functional lipid-based bioconjugates for drug delivery and other applications. , 2011, Methods in molecular biology.
[183] A. Madgulkar,et al. Preparation and Evaluation of Miconazole Nitrate-Loaded Solid Lipid Nanoparticles for Topical Delivery , 2009, AAPS PharmSciTech.
[184] M. Garnett,et al. Targeted drug conjugates: principles and progress. , 2001, Advanced drug delivery reviews.
[185] Temsamani,et al. Brain drug delivery technologies: novel approaches for transporting therapeutics. , 2000, Pharmaceutical science & technology today.
[186] Y. Olsson,et al. Observations on exsudation of fibronectin, fibrinogen and albumin in the brain after carotid infusion of hyperosmolar solutions , 2004, Acta Neuropathologica.
[187] Mansoor M. Amiji,et al. Intracellular Delivery of Saquinavir in Biodegradable Polymeric Nanoparticles for HIV/AIDS , 2006, Pharmaceutical Research.
[188] J. Huwyler,et al. Uptake of Cationized Albumin Coupled Liposomes by Cultured Porcine Brain Microvessel Endothelial Cells and Intact Brain Capillaries , 2002, Journal of drug targeting.
[189] Jia Guo,et al. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release. , 2012, Biomaterials.
[190] Simon Cawthorne,et al. Particle engineering techniques for inhaled biopharmaceuticals. , 2006, Advanced drug delivery reviews.
[191] Abraham H. Abouzeid,et al. Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin , 2013, Journal of drug targeting.
[192] G. Storm,et al. Targeting Anti—Transferrin Receptor Antibody (OX26) and OX26-Conjugated Liposomes to Brain Capillary Endothelial Cells Using In Situ Perfusion , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[193] M. Ricci,et al. Solid lipid nanoparticles for targeted brain drug delivery. , 2007, Advanced drug delivery reviews.
[194] W. Sterry,et al. Nanoparticles in dermatology , 2011, Archives of Dermatological Research.
[195] Robert J. Gillies,et al. Tumor pH and Its Measurement , 2010, The Journal of Nuclear Medicine.
[196] M. Refojo,et al. Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. , 1997, Investigative ophthalmology & visual science.
[197] Miqin Zhang,et al. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. , 2010, Advanced drug delivery reviews.
[198] J Sawynok,et al. The therapeutic use of heroin: a review of the pharmacological literature. , 1986, Canadian journal of physiology and pharmacology.
[199] W. Hennink,et al. Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[200] V. Torchilin,et al. Tatp-mediated intracellular delivery of pharmaceutical nanocarriers. , 2007, Biochemical Society transactions.
[201] P. Sinko,et al. Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs. , 2010, Advanced drug delivery reviews.
[202] Jing Zhang,et al. Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis. , 2009, Biomaterials.
[203] Jun-ichiro Jo,et al. An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[204] C. Kleinstreuer,et al. A new catheter for tumor targeting with radioactive microspheres in representative hepatic artery systems. Part I: impact of catheter presence on local blood flow and microsphere delivery. , 2012, Journal of biomechanical engineering.
[205] D. Friend,et al. A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria. , 1984, Journal of medicinal chemistry.
[206] U. Bickel,et al. In vivo demonstration of subcellular localization of anti-transferrin receptor monoclonal antibody-colloidal gold conjugate in brain capillary endothelium. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[207] C. Bucana,et al. Localization of liposomes containing a DNA repair enzyme in murine skin. , 1994, The Journal of investigative dermatology.
[208] R. Jones,et al. Oral insulin in diabetic dogs. , 1991, The Journal of endocrinology.
[209] S. Sharma,et al. Antibody directed enzyme prodrug therapy (ADEPT). A review of some theoretical, experimental and clinical aspects. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[210] Gordon L. Amidon,et al. Targeted prodrug design to optimize drug delivery , 2000, AAPS PharmSci.
[211] W. Sterry,et al. Investigation of Follicular Penetration of Topically Applied Substances , 2001, Skin Pharmacology and Physiology.
[212] M. B. Pierre,et al. Liposomal systems as drug delivery vehicles for dermal and transdermal applications , 2011, Archives of Dermatological Research.
[213] Nikolitsa Nomikou,et al. Ultrasound-enhanced drug dispersion through solid tumours and its possible role in aiding ultrasound-targeted cancer chemotherapy. , 2010, Cancer letters.
[214] Mu-Yi Hua,et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain , 2010, Proceedings of the National Academy of Sciences.
[215] M. Lakomek,et al. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats , 2002, Cancer Chemotherapy and Pharmacology.
[216] J. Lademann,et al. Penetration profile of microspheres in follicular targeting of terminal hair follicles. , 2004, The Journal of investigative dermatology.
[217] S. Vyas,et al. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages. , 2005, International journal of pharmaceutics.
[218] B. Philip,et al. Colon targeted drug delivery systems: a review on primary and novel approaches. , 2010, Oman medical journal.
[219] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[220] J. Wilce,et al. Targeting large molecules to mitochondria. , 2001, Advanced drug delivery reviews.
[221] U. Sharma,et al. The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model. , 2012, Biomaterials.
[222] Mayur M. Patel. Cutting-edge technologies in colon-targeted drug delivery systems , 2011, Expert opinion on drug delivery.
[223] Juliane Nguyen,et al. Biodegradable polymeric nanocarriers for pulmonary drug delivery , 2008 .
[224] W. Pardridge. Brain drug targeting and gene technologies. , 2001, Japanese journal of pharmacology.
[225] J. Benoit,et al. Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments. , 2007, Biomaterials.
[226] Huibi Xu,et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. , 2007, International journal of pharmaceutics.
[227] H F Edelhauser,et al. Drug delivery for posterior segment eye disease. , 2000, Investigative ophthalmology & visual science.